11-May-2007 | research and development
Nymox Announces New Positive Results from 3 1/2 Year Study of NX-1207 for Benign Prostatic Hyperplasia
Nymox Pharmaceutical Corporation announced positive results from a new long-term outcome study of NX-1207 for benign prostatic hyperplasia (BPH). The study ...